PubMed · 2015 · 15 citations · 0 references
MedicineOncologyRadiation OncologyClinical Radiation OncologyRadiation ProtectionRadiobiologyBasal Cell CarcinomaGeriatric OncologyManagement Of Acute Radiation ReactionsRadiation TherapyRadiobiological ConsiderationsRadiotherapy For Skin CancerAge-specific RadiotherapyMedian AgeRadiation Dose OptimizationRadiation Therapy ResponseRadiotherapy Dose EscalationRadiotherapy Dose PlanningTumor DosimetryTumor Radiosensitivity
AIM: A retrospective analysis was performed in our two Institutions in order to evaluate the feasibility and reliability of a hypofractionated-radiotherapy regimen in the treatment of frail elderly patients with facial basal cell carcinomas (BCCs). PATIENTS AND METHODS: The records of elderly patients (age >75 years) with histologically-confirmed BCC, T1-2, treated to a total radiation dose of 25-30 Gy over 5-6 weeks, were retrospectively analyzed. RESULTS: From February 2007-December 2010, 134 ambulatory patients with 159 BCCs were treated. Their median age was 82.5 years (range=75-103). Grade 1-2 skin acute toxicities were observed in 30.6% of patients (41/134). Complete responses were observed in 157 tumors in 132 patients. At the last follow-up, June 2014, no late toxicities had been noted; three patients had local recurrent disease. CONCLUSION: Our results seem to demonstrate both the feasibility and efficacy of curative hypofractionated radiation therapy in elderly patients with BCCs unfit for daily irradiation.